Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Care Publish Ahead of Print published online ahead of print March 23, 2007
DOI: 10.2337/dc06-1899

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dc06-1899v1
30/6/1513    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chi Lim, S.
Right arrow Articles by Sum, C. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chi Lim, S.
Right arrow Articles by Sum, C. F.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

The relationship between adrenomedullin, metabolic factors and vascular function in individuals with type 2 diabetes mellitus

Su Chi Lim1, Nils G. Morgenthaler2, Tavintharan Subramaniam1, Yew Seng Wu1, Siew Kheng Goh1 and Chee Fang Sum1

1Department of Medicine, Alexandra Hospital, Singapore
2Research Department, B.R.A.H.M.S. AG, Biotechnology Center Hennigsdorf/Berlin, Germany

Su_Chi_LIM{at}alexhosp.com.sg

ABSTRACT

Objective -: Subjects with type 2 diabetes (T2DM) are at risk for vascular injury. Several vaso-active factors (VFs) (e.g. angiotensin) have been implicated. We hypothesize that adrenomedullin, a novel VF, is deranged in subjects with T2DM.

Research design & methods -: Using a new immunoluminometric method, plasma mid-regional proADM (MR-proADM) was measured in four groups of Chinese subjects - healthy [H, N=100, fasting plasma glucose (FPG) <5.6 mM), impaired fasting glucose (IFG) (N=60, FPG 5.6-6.9 mM), diabetic with (DN, N=100) and without (DM, N=100) nephropathy. Resting forearm cutaneous micro-circulatory perfusion (RCMP) was quantified in vivo using 2-Dimensional Laser Doppler flowmetry. We investigated the relationship between plasma MR-proADM concentrations, multiple metabolic factors and vascular function.

Results -: We observed a stepwise increase in MR-proADM among the groups [mean(SD)]. H 0.27(0.09) nM/L, IFG 0.29(0.13), DM 0.42(0.13) and DN 0.81(0.54) (DM vs. H & IFG P = 0.04 and DN vs. all P<0.01). Statistical adjustment for gender, age, BMI and blood pressure did not affect the conclusions. Multiple linear regression analysis revealed that highly sensitive C-reactive protein (ß=0.11;P=0.01), insulin resistance index (ß=0.20;P=0.001), LDL-cholesterol (ß=0.31;P<0.001) and adiponectin (ß=0.33;P<0.001) were significant predictors of plasma MR-proADM concentrations among non-diabetic individuals. Among subjects with diabetes, plasma MR-proADM concentrations correlated significantly with RCMP (r=0.43, P=0.002).

Conclusions -: Plasma MR-proADM concentration was elevated in subjects with T2DM. This was further accentuated when nephropathy set in. MR-proADM was related to multiple metabolic factors and basal micro-circulatory perfusion. Adrenomedullin might play a role in the pathogenesis of diabetic vasculopathy.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.